Literature DB >> 8973766

Agonistic effects of anti-peptide antibodies and autoantibodies directed against adrenergic and cholinergic receptors: absence of desensitization.

G Wallukat1, M L Fu, Y Magnusson, A Hjalmarson, J Hoebeke, A Wollenberger.   

Abstract

Affinity-purified autoantibodies and anti-peptide antibodies directed against the second extracellular loop of the beta 1-adrenoceptor increase the beating rate of cultured cardiomyocytes just like the beta-adrenergic agonist isoprenaline. Their positive chronotropic action is blocked by beta-adrenergic antagonists. Affinity-purified autoantibodies and anti-peptide antibodies directed against the muscarinic cholinergic M2 receptor exert in these myocytes, like the muscarinic cholinergic agent carbachol, a negative chronotropic effect that is antagonized by atropine. In contrast to the agonism of isoprenaline and carbachol, the described agonistic effects of the antibodies are not subject to desensitization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8973766

Source DB:  PubMed          Journal:  Blood Press Suppl        ISSN: 0803-8023


  9 in total

Review 1.  Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.

Authors:  Gerd Wallukat; Ingolf Schimke
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

2.  Functional and structural characterization of anti-beta1-adrenoceptor autoantibodies of spontaneously hypertensive rats.

Authors:  Gerd Wallukat; Svenia Podlowski; Eberhard Nissen; Rosemarie Morwinski; Csaba Csonka; Arpad Tosaki; Ingolf E Blasig
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

3.  A peptidomimetic inhibitor suppresses the inducibility of β1-adrenergic autoantibody-mediated cardiac arrhythmias in the rabbit.

Authors:  Hongliang Li; Ling Zhang; Bing Huang; Vineet Veitla; Benjamin J Scherlag; Madeleine W Cunningham; Christopher E Aston; David C Kem; Xichun Yu
Journal:  J Interv Card Electrophysiol       Date:  2015-10-07       Impact factor: 1.900

4.  Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease.

Authors:  V Labovsky; C R Smulski; K Gómez; G Levy; M J Levin
Journal:  Clin Exp Immunol       Date:  2007-04-05       Impact factor: 4.330

Review 5.  Autoimmunological features in inflammatory cardiomyopathy.

Authors:  Angela Kallwellis-Opara; Andrea Dörner; Wolfgang-Christian Poller; Michel Noutsias; Uwe Kühl; Heinz-Peter Schultheiss; Mathias Pauschinger
Journal:  Clin Res Cardiol       Date:  2007-05-22       Impact factor: 5.460

Review 6.  Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond.

Authors:  Yang Xia; Rodney E Kellems
Journal:  Circ Res       Date:  2013-06-21       Impact factor: 17.367

7.  Mitochondrial Ultrastructural Alterations and Declined M2 Receptor Density Were Involved in Cardiac Dysfunction in Rats after Long Term Treatment with Autoantibodies against M2 Muscarinic Receptor.

Authors:  Suli Zhang; Zhongmei He; Jin Wang; Li Wang; Ye Wu; Jie Wang; Tingting Lv; Huirong Liu
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

8.  Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation.

Authors:  Charlotte Szewczykowski; Christian Mardin; Marianna Lucio; Gerd Wallukat; Jakob Hoffmanns; Thora Schröder; Franziska Raith; Lennart Rogge; Felix Heltmann; Michael Moritz; Lorenz Beitlich; Julia Schottenhamml; Martin Herrmann; Thomas Harrer; Marion Ganslmayer; Friedrich E Kruse; Martin Kräter; Jochen Guck; Robert Lämmer; Matthias Zenkel; Andreas Gießl; Bettina Hohberger
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

9.  Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma.

Authors:  Anselm Jünemann; Bettina Hohberger; Jürgen Rech; Ahmed Sheriff; Qin Fu; Ursula Schlötzer-Schrehardt; Reinhard Edmund Voll; Sabine Bartel; Hubert Kalbacher; Johan Hoebeke; Robert Rejdak; Folkert Horn; Gerd Wallukat; Rudolf Kunze; Martin Herrmann
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.